Company Monitoring Page for Takeda

latest headlines for company on cafepharma

After Sanofi’s setbacks, Takeda eyes finish line with its dengue vaccine
Pharmaforum
Mon, 05/24/21 - 10:55 am
Tags:
Takeda, clinical trials, vaccines, dengue, Sanofi, Dengvaxia, TAK-003
FDA Accepts NDA for Takeda’s Maribavir
BioSpace
Sun, 05/23/21 - 02:56 pm
Tags:
Takeda, post-transplant cytomegalovirus, CMV, maribavir, FDA
Takeda tees up priority review for storied CMV drug from its $62B Shire buyout
Endpoints
Fri, 05/21/21 - 10:51 am
Tags:
Shire, Takeda, M&A, CMV, maribavir
Takeda fleshes out case for oral EGFR drug with follow-up pivotal data in non-small cell lung cancer
Endpoints
Wed, 05/19/21 - 11:14 pm
Tags:
ASCO 2021, lung cancer, Takeda, FDA, non-small cell lung cancer
Takeda's Baxalta settles with Bayer over $173M hemophilia patent infringement verdict
Fierce Pharma
Wed, 05/19/21 - 11:05 pm
Tags:
Baxalta, Takeda, hemophilia, patents, Bayer, Adynovate
With cost cuts and asset sales largely wrapped, Takeda gears up for growth: CEO
Fierce Pharma
Tue, 05/11/21 - 11:15 am
Tags:
Takeda, debt, Pharma CEOs, Chris Weber
The retreat of corporate venture funding?
EP Vantage
Fri, 04/23/21 - 11:02 am
Tags:
funding, venture funding, venture capital, AbbVie, Amgen, Boehringer Ingelheim, Bristol Myers Squibb, Eli Lilly, GSK, JNJ, Merck, Merck KGaA, Pfizer, Roche, Sanofi, Takeda
2,400 people remain without rare disease drug as Takeda manufacturing woes continue
Endpoints
Mon, 04/5/21 - 02:55 pm
Tags:
Takeda, hypoparathyroidism, drug manufacturing, Natpara
Takeda, CSL to end alliance as plasma-based COVID-19 drug fails key test
BioPharma Dive
Mon, 04/5/21 - 02:43 pm
Tags:
Takeda, CSL Behring, COVID-19
Takeda Pharmaceutical concludes sale of OTC and non-core assets to Orifarm for $670m
Pharmaceutical Business Review
Thu, 04/1/21 - 10:50 am
Tags:
Takeda, OTC, M&A, Orifarm
Eohilia maker Takeda targets doctors in a first-time eosinophilic esophagitis awareness push
Fierce Pharma
Wed, 03/31/21 - 10:49 am
Tags:
Takeda, eosinophilic esophagitis, drug marketing
Takeda taps BridGene to pursue hard-to-drug neurodegenerative disease targets
Fierce Biotech
Tue, 03/30/21 - 11:38 am
Tags:
Takeda, BridGene Biosciences, small molecule drugs, neurodegenerative disease
Anima Biotech, Takeda Collaborate To Develop MRNA Translation Modulators For Neurological Diseases
NASDAQ
Thu, 03/18/21 - 11:06 am
Tags:
Takeda, AnimaBiotech, MRNA, drug development
Vivek Ramaswamy's LNP delivery tech play Genevant scores $600M licensing deal from Takeda for nucleic acid therapies
Endpoints
Mon, 03/15/21 - 11:10 am
Tags:
Vivek Ramaswamy, Genevant, lipid nanoparticles, Takeda
Clarivate Drugs to Watch Report Highlights Four Likely Blockbusters Among Drugs Launching in 2021
PR Newswire
Tue, 03/9/21 - 10:45 am
Tags:
Clarivate, Biogen, Eisai, aducanumab, UCB Pharma, bimekizumab, Relugolix, Pfizer, Takeda, Myovant, vericiguat, Bayer, Merck
From partner to part of the family: Takeda pulls the trigger on Maverick buyout
Fierce Biotech
Tue, 03/9/21 - 10:32 am
Tags:
Takeda, Maverick Therapeutics, M&A, T-cell engager
Pfizer's Lorbrena breaks into front-line ALK lung cancer, jostling with Novartis, Roche and Takeda
Fierce Pharma
Thu, 03/4/21 - 11:21 pm
Tags:
Pfizer, Lorbrena, non-small cell lung cancer, Novartis, Roche, Takeda
Takeda keeps divestment spree rolling with $1.2B sale of diabetes meds to Japanese firm Teijin
Fierce Pharma
Wed, 03/3/21 - 12:01 am
Tags:
Takeda, diabetes, Teijin Pharma
A closely watched schizophrenia drug fails key test
BioPharma Dive
Tue, 03/2/21 - 11:54 pm
Tags:
Neurocrine, schizophrenia, Takeda, clinical trials, luvadaxistat
Early Morphic data hint at a threat to Entyvio
EP Vantage
Mon, 03/1/21 - 11:47 pm
Tags:
Morphic Therpeuitc, Entyvio, MORF--57, Takeda

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.